PPC
LLY icon

Pennington Partners & Co’s Eli Lilly LLY Stock Holding History

Pennington Partners & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$675K Buy
734
+479
+188% +$486K 0.23% 53
2025
Q4 		$274K Buy
+255
New +$244K 0.11% 79
2025
Q2 		– Sell
-315
Closed -$260K – 85
2025
Q1 		$260K Sell
315
-265
-46% -$221K 0.15% 64
2024
Q4 		$448K Buy
+580
New +$480K 0.22% 50

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Pennington Partners & Co's LLY Position: Q1 2026 in Review

Pennington Partners & Co increased its Eli Lilly (LLY) stake by 188% in Q1 2026, buying an estimated $486K and bringing the position to 734 shares worth $675K. The position accounts for 0.23% of the portfolio, ranked #53.

Pennington Partners & Co first reported a position in LLY in Q4 2024 and has held it in 4 quarters since. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Pennington Partners & Co held 734 shares of Eli Lilly worth $675K as of Q1 2026.
  • Pennington Partners & Co bought 479 Eli Lilly shares in Q1 2026, an estimated $486K.
  • Eli Lilly made up 0.23% of Pennington Partners & Co's portfolio in Q1 2026, its #53 holding.
  • Pennington Partners & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 4 quarters since.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Pennington Partners & Co's 13F filing for Q1 2026, filed 14 May 2026.